Skip to main navigation Skip to search Skip to main content

Erratum: The efficacy of natalizumab in patients with relapsing multiple sclerosis: Subgroup analyses of AFFIRM and SENTINEL (Journal of Neurology (2009) 256 (405-415) DOI: 10.1007/s00415-009-0093-1)

  • Michael Hutchinson
  • , Ludwig Kappos
  • , Peter A. Calabresi
  • , Christian Confavreux
  • , Gavin Giovannoni
  • , Steven L. Galetta
  • , Eva Havrdova
  • , Fred D. Lublin
  • , David H. Miller
  • , Paul W. O'Connor
  • , J. Theodore Phillips
  • , Chris H. Polman
  • , Ernst Wilhelm Radue
  • , Richard A. Rudick
  • , William H. Stuart
  • , Andrzej Wajgt
  • , Bianca Weinstock-Guttman
  • , Daniel R. Wynn
  • , Frances Lynn
  • , Michael A. Panzara
  • University College Dublin
  • University of Basel
  • Johns Hopkins University
  • Hôpital neurologique et neurochirurgical Pierre Wertheimer
  • University College London
  • University of Pennsylvania
  • Charles University
  • Icahn School of Medicine at Mount Sinai
  • University of Toronto
  • Multiple Sclerosis Center at Texas Neurology
  • Vrije Universiteit Amsterdam
  • Cleveland Clinic Foundation
  • MS Center of Atlanta
  • Medical University of Silesia in Katowice
  • Consultants in Neurology Ltd
  • Biogen IDEC

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish
Pages (from-to)1035-1037
Number of pages3
JournalJournal of Neurology
Volume256
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

Dive into the research topics of 'Erratum: The efficacy of natalizumab in patients with relapsing multiple sclerosis: Subgroup analyses of AFFIRM and SENTINEL (Journal of Neurology (2009) 256 (405-415) DOI: 10.1007/s00415-009-0093-1)'. Together they form a unique fingerprint.

Cite this